NeoGenomics, Inc.
NEO · NASDAQ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 509.73M | 187.90M | -157.62M | -144.25M | -5.80 |
| 2023 FY | 591.64M | 244.60M | -107.74M | -87.97M | -3.50 |
| 2024 FY | 660.57M | 290.10M | -92.11M | -78.73M | -3.10 |
| 2025 FY | 727.33M | 282.54M | -66.08M | -108.03M | -4.20 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 1.74B | 742.01M | 263.18M | 610.93M | 998.02M |
| 2023 FY | 1.68B | 739.69M | 342.49M | 611.68M | 941.54M |
| 2024 FY | 1.64B | 735.70M | 367.01M | 605.33M | 902.34M |
| 2025 FY | 1.36B | 523.27M | 159.62M | 472.28M | 836.56M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | -65.99M | -30.89M | -96.88M | — | -53.65M |
| 2023 FY | -1.95M | -28.75M | -30.71M | — | 79.31M |
| 2024 FY | 7.02M | -41.06M | -34.04M | — | 24.52M |
| 2025 FY | 5.23M | -27.01M | -21.78M | — | -207.39M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 229.55M | 577.30M | — | — | — |
| 2023 FY | 406.12M | 675.32M | — | — | — |
| 2024 FY | 417.46M | 655.79M | — | — | — |
| 2025 FY | 301.29M | 613.95M | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 181.33M | 77.26M | -47.63M | -45.09M | -1.75 |
| 2025 Q3 | 187.80M | 80.45M | -27.01M | -27.13M | -1.05 |
| 2025 Q4 | 190.17M | 75.71M | -11.14M | -9.88M | -0.38 |
| 2026 Q1 | 186.67M | 80.86M | -18.24M | -17.11M | -0.65 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 1.39B | 539.91M | 154.72M | 411.76M | 854.04M |
| 2025 Q3 | 1.37B | 536.49M | 164.12M | 410.31M | 838.29M |
| 2025 Q4 | 1.36B | 523.27M | 159.62M | 472.28M | 836.56M |
| 2026 Q1 | 1.35B | 517.77M | 146.14M | 408.53M | 828.76M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 20.33M | -6.32M | 14.01M | — | -191.47M |
| 2025 Q3 | 8.88M | -8.31M | 570.00K | — | 9.39M |
| 2025 Q4 | 1.34M | -7.87M | -6.53M | — | -4.50M |
| 2026 Q1 | -8.14M | -5.00M | -13.14M | — | -13.48M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 187.06M | 444.10M | — | — | — |
| 2025 Q3 | 197.50M | 443.69M | — | — | — |
| 2025 Q4 | 302.58M | 615.24M | — | — | — |
| 2026 Q1 | 191.68M | 454.07M | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |